Mycosis fungoides and Sézary syndrome

Methods in Molecular Biology

Volumn 973, Issue , 2013, Pages 175-188

  Espinet, Blanca ^a   Salgado, Rocío ^a  

^a NONE

Author keywords

ACGH; Conventional cytogenetics; Genomic profile; Multicolor FISH; Mycosis fungoides; Primary cutaneous T cell lymphomas; S zary syndrome

Indexed keywords

DNA; GENOMIC DNA; TRANSCRIPTOME;

ARTICLE; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CUTANEOUS T CELL LYMPHOMA; CYTOGENETICS; DNA EXTRACTION; GENETIC MARKER; GENOMIC INSTABILITY; GENOMICS; HUMAN; MYCOSIS FUNGOIDES; OVERALL SURVIVAL; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; SEZARY SYNDROME; TISSUE PRESERVATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; SKIN TUMOR;

CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA; GENETIC MARKERS; GENOMIC INSTABILITY; HUMANS; MYCOSIS FUNGOIDES; SEZARY SYNDROME; SKIN NEOPLASMS; TRANSCRIPTOME;

MLCS; MLOWN;

EID: 84880798092     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-281-0_11     Document Type: Article

References (54)

1. Criscione VD, Weinstock M.A. (2007) Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 1437: 854-859
2. Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 10510: 3768-3785
3. Swerdlow SH, Campo E, Harris N.L., Jaffe ES, Pileri SA, Stein H et al eds (2008) World Health Organization classification of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon
4. Kuzel TM, Roenigk HH Jr, Rosen S.T. (1991) Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol 97: 1298-1313
5. Diamandidou E, Cohen PR, Kurzrock R. (1996) Mycosis fungoides and Sézary syndrome. Blood 887: 2385-2409
6. Harwix S, Gunzl HJ, Blaschke V, Zachmann K., Neumann C. (2001) Inability to culture the dominant T-cell clone from the skin of primary cutaneous T-cell lymphoma as proven by TCR gamma-chain gene sequencing. Arch Dermatol Res 2933: 139-146
7. Karenko L, Hyytinen E, Sarna S., Ranki A. (1997) Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 1081: 22-29
8. Batista DA, Vonderheid EC, Hawkins A et al (2006) Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities. Genes Chromosomes Cancer 454: 383-391
9. Padilla-Nash H.M., Wu K, Just H., Ried T, Thestrup-Pedersen K (2007) Spectral karyotyping demonstrates genetically unstable skin-homing T lymphocytes in cutaneous T-cell lymphoma. Exp Dermatol 162: 98-103
10. Karenko L, Kahkonen M, Hyytinen E.R., Lindlof M., Ranki A. (1999) Notable losses at specific regions of chromosomes 10q and 13q in the Sézary syndrome detected by comparative genomic hybridization. J Invest Dermatol 1123: 392-395
11. Mao X, Lillington D, Scarisbrick JJ et al (2002) Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides. Br J Dermatol 1473: 464-475
12. Fischer TC, Gellrich S, Muche JM et al (2004) Genomic aberrations and survival in cutaneous T cell lymphomas. J Invest Dermatol 1223: 579-586
13. Prochazkova M, Chevret E, Mainhaguiet G et al (2007) Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer 469: 828-838
14. Sole F, Woessner S, Vallespi T et al (1995) Cytogenetic abnormalities in seven patients with the Sézary syndrome. Sangre (Barc) 405: 431-433
15. Thangavelu M, Finn WG, Yelavarthi KK et al (1997) Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 899: 3371-3377
16. Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young B.D., Whittaker S. (2003) Molecular cytogenetic characterization of Sézary syndrome. Genes Chromosomes Cancer 363: 250-260
17. Espinet B, Salido M, Pujol RM et al (2004) Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situ hybridization. Haematologica 892: 165-173
18. Barba G, Matteucci C, Girolomoni G et al (2008) Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas. Cancer Genet Cytogenet 1841: 48-51
19. Karenko L, Sarna S, Kahkonen M., Ranki A. (2003) Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol 1481: 55-64
20. van Doorn R., van Kester MS, Dijkman R et al (2009) Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome. Blood 1131: 127-136
21. Salgado R, Servitje O, Gallardo F et al (2010) Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J Invest Dermatol 1304: 1126-1135
22. Laharanne E, Oumouhou N, Bonnet F et al (2010) Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol 1306: 1707-1718
23. Vermeer MH, van Doorn R, Dijkman R et al (2008) Novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 688: 2689-2698
24. Caprini E, Cristofoletti C, Arcelli D et al (2009) Identification of key regions and genes important in the pathogenesis of Sézary syndrome by combining genomic and expression microarrays. Cancer Res 6921: 8438-8446
25. Lengauer C, Kinzler KW, Vogelstein B. (1998) Genetic instabilities in human cancers. Nature 3966712: 643-649
26. Blaveri E, Brewer JL, Roydasgupta R et al (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 1119(Pt 1): 7012-7022
27. Fridlyand J, Snijders AM, Ylstra B et al (2006) Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6: 96
28. Ferreira BI, Alonso J, Carrillo J et al (2008) Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene 2714: 2084-2090
29. Ferreira BI, Garcia JF, Suela J et al (2008) Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 935: 670-679
30. Wlodarska I, Martin-Garcia N, Achten R et al (2002) Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 333: 243-251
31. Tamaska J, Adam E, Kozma A et al (2006) Hepatosplenic gamma delta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. Virchows Arch 4494: 479-483
32. Feldman AL, Law M, Grogg KL et al (2008) Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization. Am J Clin Pathol 1302: 178-185
33. Laharanne E, Chevret E, Idrissi Y et al (2010) CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. Mod Pathol 234: 547-558
34. Navas IC, Algara P, Mateo M et al (2002) p16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides. Lab Invest 822: 123-132
35. Navas IC, Ortiz-Romero PL, Villuendas R et al (2000) p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 1565: 1565-1572
36. Nobori T, Takabayashi K, Tran P et al (1996) Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci U S A 9312: 6203-6208
37. Dreyling MH, Roulston D, Bohlander S.K., Vardiman J., Olopade O.I. (1998) Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 221: 72-78
38. Christopher SA, Diegelman P, Porter C.W., Kruger W.D. (2002) Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 6222: 6639-6644
39. Subhi AL, Tang B, Balsara BR et al (2004) Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clin Cancer Res 1021: 7290-7296
40. Marce S, Balague O, Colomo L et al (2006) Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: Implications for a potential targeted therapy. Clin Cancer Res 1212: 3754-3761
41. Mirebeau D, Acquaviva C, Suciu S et al (2006) The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 917: 881-885
42. Worsham MJ, Chen KM, Tiwari N et al (2006) Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1324: 409-415
43. Kadariya Y, Yin B, Tang B et al (2009) Mice heterozygous for germ-line mutations in meth-ylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. Cancer Res 6914: 5961-5969
44. Meyer N, Kim SS, Penn L.Z. (2006) The Oscar-worthy role of myc in apoptosis. Semin Cancer Biol 164: 275-287
45. Vita M, Henriksson M. (2006) The myc onco-protein as a therapeutic target for human cancer. Semin Cancer Biol 164: 318-330
46. Dalla-Favera R., Bregni M, Erikson J., Patterson D, Gallo RC, Croce C.M. (1982) Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 7924: 7824-7827
47. Klapproth K, Wirth T. (2010) Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 1494: 484-497
48. Dezfouli S, Bakke A, Huang J., Wynshaw-Boris A, Hurlin P.J. (2006) Inflammatory disease and lymphomagenesis caused by deletion of the myc antagonist mnt in T cells. Mol Cell Biol 266: 2080-2092
49. Limon J, Nedoszytko B, Brozek I et al (1995) Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome. Cancer Genet Cytogenet 831: 75-81
50. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker S.J. (2000) Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 959: 2937-2942
51. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker S.J. (2001) Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identi fied on 9p, 10q, and 17p. J Invest Dermatol 1173: 663-670
52. Wain EM, Mitchell TJ, Russell-Jones R, Whittaker S.J. (2005) Fine mapping of chromosome 10q deletions in mycosis fungoides and Sézary syndrome: identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1. Genes Chromosomes Cancer 422: 184-192
53. Gallardo F, Esteller M, Pujol R.M., Costa C., Estrach T, Servitje O. (2004) Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas. Haematologica 8911: 1401-1403
54. van Doorn R., Zoutman WH, Dijkman R et al (2005) Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 2317: 3886-3896